share_log

藥明合聯:2023年度環境、社會及管治報告

WUXI XDC: Environmental, Social and Governance Report 2023

Hong Kong Stock Exchange ·  Apr 29 17:46
Summary by Futu AI
藥明合聯生物技術有限公司於2023年度發佈了環境、社會及管治報告,展示了公司在氣候變化與能源節約、環境保護、人才發展、健康與安全、供應鏈管理、產品責任、反貪腐及社區投資等方面的表現和進展。報告顯示,公司致力於減少溫室氣體排放,並設定了中期和長期減排目標;在廢棄物和排放控制方面,實現了100%的廢棄物處理合規率和廢水處理合規率;在人才發展方面,公司提供了多元化、平等與包容的工作環境,並進行了員工培訓;在健康與安全方面,公司實施了職業健康與安全管理體系,並進行了相關培訓和演練;在供應鏈管理方面,公司與供應商簽署了《商業行為準則》,確保供應鏈的綠色可持續發展;在產品責任方面,公司對產品和服務進行了健康與安全影響的評估;在反貪腐方面,公司建立了反貪腐政策和程序;在支持社區方面,公司積極參與社區活動並進行慈善捐贈。報告期內,藥明合聯未發生任何重大的環境或社會違規事件。
藥明合聯生物技術有限公司於2023年度發佈了環境、社會及管治報告,展示了公司在氣候變化與能源節約、環境保護、人才發展、健康與安全、供應鏈管理、產品責任、反貪腐及社區投資等方面的表現和進展。報告顯示,公司致力於減少溫室氣體排放,並設定了中期和長期減排目標;在廢棄物和排放控制方面,實現了100%的廢棄物處理合規率和廢水處理合規率;在人才發展方面,公司提供了多元化、平等與包容的工作環境,並進行了員工培訓;在健康與安全方面,公司實施了職業健康與安全管理體系,並進行了相關培訓和演練;在供應鏈管理方面,公司與供應商簽署了《商業行為準則》,確保供應鏈的綠色可持續發展;在產品責任方面,公司對產品和服務進行了健康與安全影響的評估;在反貪腐方面,公司建立了反貪腐政策和程序;在支持社區方面,公司積極參與社區活動並進行慈善捐贈。報告期內,藥明合聯未發生任何重大的環境或社會違規事件。
YUMING UNITED BIOTECHNOLOGY CO., LTD. PUBLISHED ITS ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT IN 2023, SHOWING THE COMPANY'S PERFORMANCE AND PROGRESS IN CLIMATE CHANGE AND ENERGY CONSERVATION, ENVIRONMENTAL PROTECTION, TALENT DEVELOPMENT, HEALTH AND SAFETY, SUPPLY CHAIN MANAGEMENT, PRODUCT ACCOUNTABILITY, ANTI-CORRUPTION AND COMMUNITY INVESTMENT. The report shows that the company is committed to reducing greenhouse gas emissions and has set medium and long-term emission reduction targets; in terms of waste and emission control, it achieves 100% waste treatment compliance and wastewater treatment compliance rates; in terms of talent development, the company provides a diverse, equitable and inclusive work environment. and conducted employee training; in health and safety, the company implemented an occupational health and safety management system, and conducted related training...Show More
YUMING UNITED BIOTECHNOLOGY CO., LTD. PUBLISHED ITS ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT IN 2023, SHOWING THE COMPANY'S PERFORMANCE AND PROGRESS IN CLIMATE CHANGE AND ENERGY CONSERVATION, ENVIRONMENTAL PROTECTION, TALENT DEVELOPMENT, HEALTH AND SAFETY, SUPPLY CHAIN MANAGEMENT, PRODUCT ACCOUNTABILITY, ANTI-CORRUPTION AND COMMUNITY INVESTMENT. The report shows that the company is committed to reducing greenhouse gas emissions and has set medium and long-term emission reduction targets; in terms of waste and emission control, it achieves 100% waste treatment compliance and wastewater treatment compliance rates; in terms of talent development, the company provides a diverse, equitable and inclusive work environment. and conducted employee training; in health and safety, the company implemented an occupational health and safety management system, and conducted related training and exercises; in supply chain management, the company and suppliers signed a Code of Business Conduct to ensure the green sustainability of the supply chain; in products In terms of responsibility, the company evaluates the health and safety impact of products and services; in anti-corruption, the company establishes anti-corruption policies and procedures; in support of the community, the company actively participates in community activities and makes charitable donations. During the reporting period, there were no major environmental or social violations by the Pharmaceutical Union.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.